Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of varenicline plus combination nicotine replacement therapy and counselling for smoking cessation in homeless or at-risk men
ACTRN12619001564145Phase 4Not yet recruiting
- Sponsor
- The University of Newcastle
- Start
- Nov 2019
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varenicline and nicotine patch in nicotine dependence, sponsored by The University of Newcastle. Primary endpoint: Safety. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
vareniclinenicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12619001564145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001564145.